Dr Ross MacIntyre
Cataract, Corneal and Refractive Surgeon
← Back to Blog
Cataract Surgery14 May 2026

Dry Eye and Cataract Surgery — What You Need to Know Before Your Operation

By Dr Ross MacIntyre MD FRANZCO

Dry eye disease is the most commonly overlooked factor in cataract surgery planning, and the most common cause of disappointing vision after an otherwise technically perfect operation. Understanding how dry eye affects cataract surgery outcomes, and what can be done about it, is essential for anyone considering the procedure.

What is dry eye disease?

Dry eye disease (DED) is a chronic condition in which the tear film is insufficient, unstable, or of poor quality. It affects an estimated 15 to 20 per cent of Australian adults and becomes more prevalent with age. Symptoms include intermittent or persistent blurred vision, burning, grittiness, and paradoxical reflex tearing. The most common cause in Australia is meibomian gland dysfunction, in which blocked eyelid glands deplete the protective lipid layer of the tear film.

Dry eye disease (DED) occurs when the tear film, the thin liquid layer that covers the front surface of the eye, is unstable, insufficient, or of poor quality. The result is intermittent or persistent blurred vision, burning, stinging, grittiness, or paradoxical reflex tearing. It is extremely common, affecting an estimated 15 to 20 per cent of Australian adults, and becomes more prevalent with age.

The tear film is not simply water. It has three layers: a mucin layer produced by goblet cells in the conjunctiva, an aqueous layer produced by the lacrimal gland, and a lipid layer produced by the meibomian glands in the eyelid margins. Dysfunction of any layer produces an unstable tear film. The most common cause in Australia is meibomian gland dysfunction (MGD), in which the meibomian glands become obstructed and the lipid layer is depleted.

Why dry eye matters so much for cataract surgery

Dry eye affects cataract surgery in two critical ways. First, an unstable tear film reduces the accuracy of pre-operative biometry, the measurements used to calculate IOL power, which can result in a refractive surprise after an otherwise technically successful operation. Second, cataract surgery itself worsens dry eye by disrupting corneal nerves, causing further tear film instability and blurred or fluctuating vision in the weeks following surgery.

There are two critical ways in which dry eye affects cataract surgery outcomes.

The first is biometry accuracy. Before cataract surgery, precise measurements of the eye (corneal curvature, axial length, and anterior chamber depth) are used to calculate the power of the intraocular lens implant. These measurements depend on a smooth, stable corneal surface. An irregular tear film produces inaccurate readings, which translates directly into errors in IOL power selection. Even a small error in biometry can mean the difference between excellent uncorrected vision and the need for glasses after surgery.

The second is post-operative visual quality. After cataract surgery, the surgical incisions temporarily disrupt corneal nerves, reducing corneal sensitivity and further impairing tear film stability. Patients with pre-existing dry eye almost always experience a worsening of symptoms in the weeks following cataract surgery. In patients with significant untreated dry eye, this can result in persistently blurred or fluctuating vision that is entirely attributable to the ocular surface rather than the IOL or the surgical technique.

This is particularly important for patients choosing premium IOLs. Multifocal and EDOF lenses are more sensitive to any optical irregularity than standard monofocal lenses. A patient with significant dry eye who receives a multifocal IOL is at high risk of halos, glare, and ghosting that may be impossible to resolve without first treating the underlying ocular surface disease.

How dry eye is assessed before cataract surgery

Pre-operative dry eye assessment is a routine part of cataract surgery planning. It includes slit-lamp examination of the eyelid margins and meibomian glands, measurement of tear film break-up time, fluorescein corneal staining to detect epithelial disruption, and review of corneal topography for surface irregularity. Where significant dry eye is found, it is treated before biometry measurements are finalised to ensure an accurate IOL power calculation.

A thorough pre-operative assessment for cataract surgery at our practice includes evaluation of the ocular surface as a routine step. This involves examination of the meibomian glands and lid margins, assessment of tear film break-up time, corneal staining with fluorescein to identify epithelial disruption, and conjunctival staining where indicated. Topographic data from corneal mapping is also reviewed for irregularity suggestive of tear film instability.

Where significant dry eye is identified before surgery, it is treated before biometry measurements are finalised. This is not a delay; it is the correct sequence to ensure accurate IOL calculation and the best possible visual outcome.

Treatment options for dry eye before cataract surgery

Treatment of dry eye before cataract surgery is tailored to the underlying cause. For meibomian gland dysfunction, the most common cause, warm compresses, lid hygiene, omega-3 supplementation, and in-office meibomian gland expression are first-line options. For aqueous deficiency, preservative-free lubricating drops and lacrimal punctal occlusion are used. Patients with moderate to severe disease may benefit from topical cyclosporine or intense pulsed light (IPL) therapy in the months before surgery.

Treatment is tailored to the underlying cause. For meibomian gland dysfunction, options include warm compress therapy, lid hygiene, omega-3 supplementation, topical azithromycin, and in-office procedures such as meibomian gland expression. For aqueous deficiency, preservative-free artificial tear drops and lacrimal punctal occlusion are effective.

For patients with moderate to severe dry eye, a course of topical cyclosporine (Cequa or Ikervis) may be initiated several months before surgery to reduce ocular surface inflammation and improve goblet cell density. In selected patients, intense pulsed light (IPL) therapy targeting the meibomian glands has shown significant benefit.

What to expect after cataract surgery if you have dry eye

Most patients experience some worsening of dry eye symptoms in the first four to eight weeks after cataract surgery as corneal nerves regenerate. Using preservative-free lubricating drops frequently during this period reduces discomfort and supports corneal healing. In most patients, symptoms return to their pre-operative baseline or better by three months after surgery. Patients with known dry eye should discuss this with their surgeon before the operation so that drop frequency and follow-up timing can be planned accordingly.

All patients undergoing cataract surgery should expect some temporary worsening of dry eye symptoms in the first four to eight weeks after the operation. Using preservative-free lubricating drops frequently (at least four times daily) during this period minimises symptoms and supports corneal healing.

Patients with known dry eye should discuss this with their surgeon before the operation so that post-operative drop frequency, follow-up timing, and the appropriateness of premium IOL selection can be planned accordingly.

If you have been told you have dry eyes and are considering cataract surgery, or if your optometrist has recommended cataract assessment, please mention your dry eye symptoms at your first consultation. Optimising the ocular surface before surgery is one of the most important steps we can take to ensure an excellent outcome.

To book a cataract surgery assessment with Dr Ross MacIntyre at Northern Eye Consultants, Bundoora, please contact us through northerneyeconsultants.com.au/contact.

← Back to all articles
FAQ

Frequently Asked Questions

Have a question about your eye health?

Dr Ross MacIntyre consults at Northern Eye Consultants in Bundoora. Book an appointment →